# Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

Source: https://onco.cc/trials/nct07155525/  
OnCo record `nct07155525` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in pancreatic cancer, run by Minia University, now recruiting.

## Summary

Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas is a phase 3, randomised interventional study registered as NCT07155525 by Minia University, with a registry enrolment figure of 194 participants, started 2025-09-15 and due to reach its primary completion in 2028-09-15. Interventions recorded: Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2); Standard(duct-to-mucosa) Pancreaticojejunostomy. Conditions listed: Pancreatic Cancer; Periampullary Cancer; Duodenal Cancer; Cholangiocarcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Head Mass; Bile Duct Cancer. Primary outcome: Incidence of Postoperative Pancreatic Fistula (POPF).. Pancreatic eligibility wording from the registry: "* Patients scheduled for elective pancreaticoduodenectomy for malignant lesions". Sites: Egypt. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: NBCA-MS
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07155525
- Phase: 3
- Setting: Pancreaticojejunostomy With or Without Modified N-butyl-2-cyanoacrylate Following Pancreaticoduodenectomy in Soft Pancreas: Randomized Controlled Trial
- Sponsor: Minia University
- Enrolled: 194

## Sources

- ClinicalTrials.gov NCT07155525: https://clinicaltrials.gov/study/NCT07155525

## Connected records

- cancers: [Resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/resectable-pdac/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07155525.json